Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.
NCT03589313
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
GLPG3067 single dose
Sponsor
Lakefront Biotherapeutics NV